Phase 1b/2 findings showed that the investigational anti-amyloid monoclonal antibody ABBV-916 produced dose-dependent ...
In recognition of SMA Awareness Month, NeurologyLive® spoke with neuromuscular experts about how multidisciplinary care is ...
Casey*, now in his 30s, recalls that period clearly. As a high school senior, Casey ate dinner after sports practice, went straight to bed, and spent up to 12 hours each night trying to sleep. Despite ...
A phase 1 feasibility trial found that placing GammaTile radiation therapy directly into the surgical cavity during ...
NeurologyLive Brain Games is a weekly, Sunday-morning quiz series featuring three questions authored by clinicians and ...
The FDA was busy early this month, during the week of August 23, 2026, making a number of decisions on potential new ...
In honor of SMA Awareness Month, held annually throughout August, get caught up on the latest news in spinal muscular atrophy ...
Updates to the MRI Protocol and Clinical Guidelines for MS: CMSC Working Group | Peer Exchange | NeurologyLive is your direct connection to the latest neurology news and interviews with expert ...
The FDA has been busy this week, making multiple decisions over just a few days. The administration kicked off the week by ...
The vice president of Neuroscience and Vaccines at Takeda discusses the clinical significance of oveporexton's FDA approval ...
Cellenkos’ investigational allogeneic, cord blood-derived T-regulatory cell therapy is being evaluated in a phase 1/1b study in ALS, with early findings showing reductions in plasma neurofilament ...
In recognition of SMA Awareness Month, held annually throughout August, NeurologyLive® reviews the investigational agents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results